Elecsys® GDF-15
... )31276-4. Wollert, K.C., Kempf, T., Peter, T. et al. (2007). Prognostic value of growthdifferentiation ... ., Peter, T. et al. (2007). Prognostic utility of growth differentiation factor-15 in patients with chronic ... ., Kempf, T., Peter, T. et al. (2007). Prognostic value of growthdifferentiation factor-15 in patients with ... ). Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll ...
Elecsys® AFP
... Carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996;77,11:2217 ... . Prognostic features, treatment outcome, and survival. Cancer 1996;77,11:2217-2222. Heimbach JK, Kulik LM ...
Cartera de productos de IHQ/HIS para cáncer de mama de Roche
... Immunohistochem Mol Morphol.2013; 21(2):139-147. Yamamoto-Ibusuki M. et al. Comparison of prognostic values ... tumors of the upper urinary tract as related to established prognostic factors and long-term survival ... . Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone ... prognostic factors and long-term survival. Arch Esp Urol. 1998.51(2): 204-210. Bacchi CE, Gown AM. Detection ...
Panel de IHQ para cáncer y hematopatología
... conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B ... lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and ...
Elecsys® IL-6
... diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis 2013;75(4):342-347 ... SY, Lee J, et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis ...
